Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shockwave Medical
MedTech
J&J trials IVL-first strategy in women with blocked coronaries
The trial tested Shockwave Medical's vessel-clearing approach as the primary procedure for women with calcified blockages in the coronary arteries.
Conor Hale
May 20, 2025 11:45am
J&J's Shockwave to test Javelin lithotripsy in coronary arteries
Apr 7, 2025 10:50am
J&J's Shockwave launches path-clearing Javelin catheter in PAD
Mar 5, 2025 10:47am
J&J pitches Shockwave as its next billion-dollar company
Jul 17, 2024 11:46am
J&J CEO says M&A strategy to 'continue' after medtech megadeals
Apr 16, 2024 1:42pm
J&J adds Shockwave to its cardio collection with $13.1B deal
Apr 5, 2024 11:00am
